Table of Contents
1. Introduction
2. Structure of the pocket guidelines and how to use it
3. Public awareness and intervention
4. Diagnostic evaluation
4.1. Diagnostic evaluation at first presentation with VA
Scenario 1: patients presenting with an incidental finding of NSVT
Scenario 2: patients presenting with a first SMVT episode
Sudden cardiac arrest survivors
Scenario 3: evaluation of SCA survivors
Sudden cardiac death victims and relatives of SADS decedents
Scenario 4: Evaluation of SD victims.
Scenario 5: Evaluation of relatives of SADS decedents
4.2. Genetic testing
5. Acute management of VA
6. Long-term management – drug treatment. General aspects
7. Long-term management – device treatment. General aspects
8. Diagnostic evaluation, management, and risk stratification according to clinical presentation and known (likely) disease
8.1. Coronary artery disease and coronary anomalies
8.2. Idiopathic PVC/VT and PVC induced/aggravated cardiomyopathy
8.3. Cardiomyopathies
8.4. Neuromuscular diseases
8.5. Inflammatory cardiac diseases
8.6. Valvular heart disease
8.7. Congenital heart disease
8.8. Primary electrical disease
Idiopathic VF
Long QT syndrome
Andersen-Tawil syndrome type 1
Brugada syndrome
Early repolarization syndrome
Cathecolaminergic polymorphic ventricular tachycardia
Short QT syndrome
9. Selected populations